Olainfarm Will Not Be Affected By Ongoing Tensions, Says Chairman
News: Latvia-based pharmaceutical company OlainFarm's sales to Ukraine and Russia will not be significantly affected by the ongoing standoff between the two countries. The two markets are extremely crucial for the company, which hopes that the current situation will be resolved amicably, Olainfarm's Chairman Valerijs Maligins has stated. The company's sales to Ukraine rose 4% year-on-year in January 2014, with Russia, Latvia, Ukraine, Belarus, the UK and the Netherlands the company's main markets for sales during the same month. However, if the EU and its allies fail to resolve the dispute in Ukraine, the Olainfarm's sales could be negatively impacted in both Ukraine and Russia.